Penn study finds advanced pulmonary embolism treatments have low rates of use across the nation

Pulmonary embolism (PE), a blood clot in the lungs which causes shortness of breath and chest pain, is the third leading cardiovascular cause of death in the United States with more than 100, 000 lives taken each year. A typical intervention for PE patients includes anticoagulants in an effort to prevent migration of the blood ["]

The post Penn study finds advanced pulmonary embolism treatments have low rates of use across the nation appeared first on Outbreak News Today.